Allogeneic stem cell transplantation in acute myeloid leukemia

被引：1

作者：

Ali, Natasha ^{[1
]}

Adil, Salman Naseem ^{[1
]}

Shaikh, Mohammad Usman ^{[1
]}

Masood, Nehal ^{[2
]}

机构：

[1] Aga Khan Univ Hosp, Dept Pathol & Microbiol, POB 3500,Stadium Rd, Karachi 74800, Pakistan

[2] Aga Khan Univ Hosp, Dept Med, Karachi, Pakistan

来源：

HEMATOLOGY REPORTS | 2012年 / 4卷 / 04期

关键词：

allogeneic transplant; acute myeloid leukemia; outcome;

D O I：

10.4081/hr.2012.e25

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report a case series of 12 patients with acute myeloid leukemia who underwent allogeneic stem cell transplant with a matched related donor. Male to female ratio was 1:1. The main complication post-transplant was graft-versus-host disease (n=7 patients). Transplant-related mortality involved one patient; cause of death was multi-organ failure. After a median follow up of 36.0 +/- 11.3 months, overall survival was 16%.

引用

页码：95 / 97

页数：3

共 18 条

[1] Age and acute myeloid leukemia [J].

Appelbaum, FR ;

Gundacker, H ;

Head, DR ;

Slovak, ML ;

Willman, CL ;

Godwin, JE ;

Anderson, JE ;

Petersdorf, SH .

BLOOD, 2006, 107 (09) :3481-3485

[2] High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: A study by the north American marrow transplant group [J].

Brown, RA ;

Wolff, SN ;

Fay, JW ;

Pineiro, L ;

Collins, RH ;

Lynch, JP ;

Stevens, D ;

Greer, J ;

Herzig, RH ;

Herzig, GP .

LEUKEMIA & LYMPHOMA, 1996, 22 (3-4) :271-277

[3] Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure [J].

Duval, Michel ;

Klein, John P. ;

He, Wensheng ;

Cahn, Jean-Yves ;

Cairo, Mitchell ;

Camitta, Bruce M. ;

Kamble, Rammurti ;

Copelan, Edward ;

de Lima, Marcos ;

Gupta, Vikas ;

Keating, Armand ;

Lazarus, Hillard M. ;

Litzow, Mark R. ;

Marks, David I. ;

Maziarz, Richard T. ;

Rizzieri, David A. ;

Schiller, Gary ;

Schultz, Kirk R. ;

Tallman, Martin S. ;

Weisdorf, Daniel .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) :3730-3738

[4]

Ferrant A, 1997, BLOOD, V90, P2931

[5] EBMT activity survey 2004 and changes in disease indication over the past 15 years [J].

Gratwohl, A. ;

Baldomero, H. ;

Frauendorfer, K. ;

Urbano-Ispizua, A. .

BONE MARROW TRANSPLANTATION, 2006, 37 (12) :1069-1085

[6] Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: An intent-to-treat long-term analysis of the BGMT experience [J].

Jourdan, E ;

Boiron, JM ;

Dastugue, N ;

Vey, N ;

Marit, G ;

Rigal-Huguet, F ;

Molina, L ;

Fegueux, N ;

Pigneux, A ;

Recher, C ;

Rossi, JF ;

Attal, M ;

Sotto, JJ ;

Maraninchi, D ;

Reiffers, J ;

Bardou, VJ ;

Esterni, B ;

Blaise, D .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7676-7684

[7]

Kakepoto G N, 2002, J Pak Med Assoc, V52, P482

[8] Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party [J].

Kataoka, I ;

Kami, M ;

Takahashi, S ;

Kodera, Y ;

Miyawaki, S ;

Hirabayashi, N ;

Okamoto, S ;

Matsumoto, N ;

Miyazaki, Y ;

Morishita, Y ;

Asai, O ;

Maruta, A ;

Yoshida, T ;

Imamura, M ;

Hamajima, N ;

Matsuo, K ;

Harada, M ;

Mineishi, S .

BONE MARROW TRANSPLANTATION, 2004, 34 (08) :711-719

[9] Peripheral blood progenitor cell or bone marrow transplantation: controversy remains [J].

Koca, Ebru ;

Champlin, Richard E. .

CURRENT OPINION IN ONCOLOGY, 2008, 20 (02) :220-226

[10] Medical progress -: Acute myeloid leukemia [J].

Löwenberg, B ;

Downing, JR ;

Burnett, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1051-1062

← 1 2 →